ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
September 20, 2024 13:45 ET
|
ONWARD Medical NV
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par...
Mullen Group Ltd. Announces Declaration of Monthly Dividend
September 20, 2024 13:15 ET
|
Mullen Group Ltd
OKOTOKS, Alberta, Sept. 20, 2024 (GLOBE NEWSWIRE) -- (TSX: MTL) The Board of Directors of Mullen Group Ltd. ("Mullen Group", "We", "Our" and/or the "Corporation") announced today that it has...
LEADING EDGE REPORTS QUARTERLY RESULTS TO JULY 31, 2024
September 20, 2024 13:00 ET
|
Leading Edge Materials Corp.
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2024 Vancouver, September 20, 2024– Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First...
Notification of major shareholding
September 20, 2024 12:46 ET
|
Nkt A/S
Company Announcement 20 September 2024Announcement No. 33 Notification of major shareholding With reference to Section 30 of the Danish Capital Market Act, NKT A/S has been...
Transaction in Own Shares
September 20, 2024 12:36 ET
|
Shell plc
Transaction in Own Shares 20 September, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 20 September 2024 it purchased the following number of Shares for...
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
September 20, 2024 12:08 ET
|
Zevra Therapeutics
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative diseaseMIPLYFFA is indicated for use in combination with miglustat...
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
September 20, 2024 11:59 ET
|
Trxade Health, Inc.
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced...
Music Licensing, Inc. (OTC: SONG) Receives Royalty Payment for Ownership Stake in Listerine Antiseptic
September 20, 2024 11:55 ET
|
Music Licensing, Inc.
Naples, FL, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG), a diversified holding company, is pleased to announce the receipt of a royalty payment derived from its ownership...
Half-year report
September 20, 2024 11:50 ET
|
Oxford Technology 2 VCT plc
Half-Year Report Oxford Technology 2 VCT plc (the "Company") Legal Entity Identifier: 2138002COY2EXJDHWB30 Unaudited Half Year Report to 31 August 2024 The unaudited NAV per share...
Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
September 20, 2024 11:45 ET
|
Onconetix, Inc.
CINCINNATI, Ohio, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and...